Biotech Values

[DewDiligence]

ENLV +48% on n=5 COVID data:

https://finance.yahoo.com/news/enlivex-reports-positive-allocetra-trial-100000050.html

Enlivex Therapeutics Ltd…today reported positive top-line results of an investigator-initiated clinical trial of Allocetra in COVID-19 patients in severe/critical condition.

The clinical trial included five COVID-19 patients, three in severe condition and two in critical condition. All five patients had complete recovery from their respective severe/critical condition and were released from the hospital after an average of 5.5 days (severe) and 8.5 days (critical), following administration of Allocetra, at which time they were all COVID-19 PCR negative. There were no reported severe adverse events relating to the administration of Allocetra in the patients, and the therapy was well-tolerated.

Caveat emptor.